The global brain imaging modalities market report highlights that the market was valued at $12,334.2 million in 2021 and is expected to reach $20,209.2 million by the end of 2031. The market is expected to grow at a CAGR of 5.06% during the forecast period 2022-2031 .
The high prevalence and growing incidences of brain diseases and neurogenerative disorders and the technological advancements in brain imaging modalities and systems are the key propellers for the growth of the market. Five key modalities of brain imaging modalities include computed tomography (CT) devices, magnetic resonance imaging (MRI) devices, positron emission tomography (PET) devices, PET-CT devices, and PET MRI devices. The field of cognitive neuroscience has emerged and developed rapidly over the last 20 years. To address the neural underpinnings of human cognition, this new field combines two traditionally separate disciplines, cognitive psychology and neurology.
Market Segmentation
Global Brain Imaging Modalities Market Opportunities
High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global brain imaging modalities market growth. In an era of machine learning and artificial intelligence, extracting quantitative biomarkers from medical images to aid illness detection, characterization, monitoring, and therapy response assessment is becoming increasingly desirable.
Key Market Players and Competition Synopsis
Some key players operating in the market include Aspect Imaging, Canon, Inc., Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., Mediso Medical Imaging Systems, MinFound Medical Systems Co., Ltd., Samsung Electronics Co., Ltd., Shenzhen Anke High-Tech Co.,Ltd., Shimadzu Corporation, Siemens Healthineers AG, United Imaging Healthcare Co., Ltd., and VUNO Co., Ltd.
Some strategies covered in this segment are funding activities, mergers and acquisitions (MAs), partnerships, alliances, business expansion, regulatory and legal activities, and new offerings.
Key Questions Answered in the Report
How has COVID-19 impacted the growth of the global brain imaging modalities market?
What are the key regulations governing the brain imaging modalities market in key regions?
What technological developments are projected to have the maximum influence on the global brain imaging modalities market?
Who are the leading players holding significant dominance in the global brain imaging modalities market?
What are some of the growth opportunities which market players can capitalize on?
What are the drivers and restraints for the global brain imaging modalities market?
Which region has the highest growth rate in the brain imaging modalities market?
Which are the fastest growing countries in terms of the global brain imaging modalities market?
What are the key strategies being adopted by market players in the global brain imaging modalities market?
Which are the emerging companies in the global brain imaging modalities market?
Assuming that the reader is a manufacturer of brain imaging modalities, the report will assist them in the following ways:
Understand their position compared to other key players in the market Stay updated with novel technology integration, features, and the latest developments in the market Understand the impact of COVID-19 on brain imaging and the entry barriers for new companies Gain insights into end-user perception concerning the brain imaging modalities market Identify some key players in the market and understand their valuable contribution